Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Oerline

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neurourology and Urodynamics|October 21, 2021
Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetesShivani Bakre, Sarah K Holt, Mary Oerline, et al.
Cancer Medicine|September 9, 2025
Outcomes of Novel Hormonal Therapies in Men With Advanced Prostate Cancer by Treating SpecialistKassem S Faraj, Mary Oerline, Samuel Kaufman, et al.
Annals of Surgery|April 29, 2021
Effects of Advanced Practice Providers on Single-specialty Surgical PracticeBrent K Hollenbeck, Samuel R Kaufman, Mary Oerline, et al.
Urology Practice|April 27, 2023
Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate CancerLillian Y Lai, Samuel R Kaufman, Mary Oerline, et al.
Annals of Surgery|January 3, 2019
Understanding the Costs Associated With Surgical Care Delivery in the Medicare PopulationDeborah R Kaye, Amy N Luckenbaugh, Mary Oerline, et al.
Journal of Oncology Practice|May 20, 2014
Implementation of a hospital-based quality assessment program for rectal cancerSamantha Hendren, Ellen McKeown, Arden M Morris, et al.
Urology|October 19, 2020
Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted TherapiesBrent K Hollenbeck, Mary Oerline, Samuel R Kaufman, et al.
Urology|October 27, 2018
Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and SpendingParth K Modi, Brent K Hollenbeck, Mary Oerline, et al.
Cancer Medicine|December 31, 2024
The 340B Drug Pricing Program and Management of Advanced Prostate CancerKassem S Faraj, Samuel R Kaufman, Mary Oerline, et al.
Journal of the National Cancer Institute|July 25, 2024
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitorsKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neurourology and Urodynamics|October 21, 2021
Longitudinal patterns of urinary incontinence and associated predictors in women with type 1 diabetesShivani Bakre, Sarah K Holt, Mary Oerline, et al.
Cancer Medicine|September 9, 2025
Outcomes of Novel Hormonal Therapies in Men With Advanced Prostate Cancer by Treating SpecialistKassem S Faraj, Mary Oerline, Samuel Kaufman, et al.
Annals of Surgery|April 29, 2021
Effects of Advanced Practice Providers on Single-specialty Surgical PracticeBrent K Hollenbeck, Samuel R Kaufman, Mary Oerline, et al.
Urology Practice|April 27, 2023
Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate CancerLillian Y Lai, Samuel R Kaufman, Mary Oerline, et al.
Annals of Surgery|January 3, 2019
Understanding the Costs Associated With Surgical Care Delivery in the Medicare PopulationDeborah R Kaye, Amy N Luckenbaugh, Mary Oerline, et al.
Journal of Oncology Practice|May 20, 2014
Implementation of a hospital-based quality assessment program for rectal cancerSamantha Hendren, Ellen McKeown, Arden M Morris, et al.
Urology|October 19, 2020
Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted TherapiesBrent K Hollenbeck, Mary Oerline, Samuel R Kaufman, et al.
Urology|October 27, 2018
Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and SpendingParth K Modi, Brent K Hollenbeck, Mary Oerline, et al.
Cancer Medicine|December 31, 2024
The 340B Drug Pricing Program and Management of Advanced Prostate CancerKassem S Faraj, Samuel R Kaufman, Mary Oerline, et al.
Journal of the National Cancer Institute|July 25, 2024
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitorsKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Pageof 3